Search results
Results from the WOW.Com Content Network
The Peugeot 106 is a supermini produced by French automaker Peugeot between 1991 and 2003. Launched in September 1991, it was Peugeot's entry level offering throughout its production life, and was initially sold only as a three-door hatchback , with a five-door hatchback joining the range in the beginning of 1992.
The TUD engine was only used in 11 cars of which 6 were non-PSA models: the Citroën AX, Citroën Saxo, Citroën Xsara; Peugeot 106, Rover Metro/100-series, Nissan Micra, Maruti Suzuki Zen D/Di and Maruti Suzuki Esteem D/Di and IKCO Samand, and the Tata Indigo 1.4 TD. The Tata's is a smaller version of the TUD engine, based on the 1.5D.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Peugeot_106_XSi&oldid=434044610"
The plant’s top sellers to date have been the Peugeot 205 and the Peugeot 106 with 2.2 million of each produced at Mulhouse. [2] Since 2004, Mulhouse output has also included Citroën badged vehicles starting with the Citroën C4 and, more recently, the DS4. Production of the Peugeot 308 was initially shared with the nearby Sochaux plant ...
L.A. firefighters look for hot spots as they prepare for high winds in the burn areas of the Palisades fire on Tuesday, Jan. 14. (Brian van der Brug/Los Angeles Times)
Five baby-faced crooks wielding a baseball bat, a knife and pieces of wood mugged a straphanger before shoving him out of a Brooklyn subway car during his early-morning commute last week, cops said.
The Saxo was a development of the Citroën AX and Peugeot 106, which shared a platform and running gear (the major difference being interiors and body panels). It was discontinued in 2003, when it was replaced with the Citroën C2 and Citroën C3 which launched a year earlier. Both models were developed alongside the Peugeot 206.
The hospice business has undergone a dramatic transformation over the past decade, from a collection of small religious-affiliated entities into a booming mega industry dominated by companies seeking to reap big profits from the business of dying.